Inactive Instrument
Acticor Biotech SAS Stock Euronext Paris
Stocks
ALACT
FR0014005OJ5
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Avenard
CEO | Chief Executive Officer | - | 2013-11-25 |
Francois Guillet
DFI | Director of Finance/CFO | 68 | 2024-10-12 |
Anouar Sari
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Avenard
BRD | Director/Board Member | - | 2013-11-25 |
Catherine Boule
BRD | Director/Board Member | - | - |
Alain Parthoens
BRD | Director/Board Member | 66 | 2018-10-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 12.69M | ||
| +2.87% | +1.58% | +68.97% | +122.28% | 55.19B | ||
| +4.00% | +7.14% | +63.67% | +68.77% | 45.75B | ||
| -0.77% | -0.39% | -15.34% | -16.07% | 22.98B | ||
| +2.93% | +0.77% | -3.97% | +376.58% | 20.76B | ||
| -0.26% | -1.09% | +27.55% | -18.57% | 16.26B | ||
| +1.16% | +2.25% | +20.23% | -35.78% | 15.42B | ||
| -1.08% | -3.35% | +27.20% | +170.12% | 13.05B | ||
| +3.30% | +15.38% | +133.24% | +273.89% | 12.45B | ||
| -5.63% | -5.49% | +21.79% | - | 12.37B | ||
| Average | +0.65% | +3.15% | +38.15% | +117.65% | 23.8B | |
| Weighted average by Cap. | +1.66% | +2.66% | +43.54% | +109.58% |
Employees
31
















